For citations:
Radygina T.V., Illarionov A.S., Petrichuk S.V., Kuptsova D.G., Kurbatova O.V., Fisenko A.P., Potapov A.S., Semikina E.L., Anushenko A.O. The use of drug monitoring of infliximab and adalimumab to optimize the treatment of inflammatory bowel diseases in children. Russian Pediatric Journal. 2022;25(5):313-320. (In Russ.) https://doi.org/10.46563/1560-9561-2022-25-5-313-320. EDN: xwnmqw
Email this article 